Epidemiological and Biological Profiling of Breast Cancer in Southern Morocco


Breast cancer
Human epidermal growth factor receptor 2 (HER-2)
Histological grade
Hormone receptors
Southern Morocco


How to Cite

Aznag FZ, Elouilamine E, Basselam MA, Chadli S, Ait El Cadi M, Izaabel E hassan. Epidemiological and Biological Profiling of Breast Cancer in Southern Morocco. Integr J Med Sci [Internet]. 2018 Feb. 3 [cited 2022 Oct. 5];5. Available from: https://www.mbmj.org/index.php/ijms/article/view/88


Breast cancer is one of the most frequent cancers that affect women. Risk factors include a combination of multiple factors such as heredity, age, and environment. The frequency of breast cancer in Morocco increased significantly in recent years, and it is now a major public health concern.
A retrospective epidemiological study was produced for a cohort of 1559 patients attending the regional center of oncology and radiotherapy in Agadir, during a period comprised between January 2010 and December 2015.
Our data shows that the average age of the patients is 48 years, the majority of them present grade II tumors 66.38%. The immunohistochemical analysis of tumors revealed that 64% of them are positive for hormone receptors. With 67.07% is positive for ER and 61.01% positive for RP, while 29.17% of tumors overexpress the HER2 protein. The distribution of molecular subtypes of breast cancer shows that luminal A has the highest percentage 50.96% followed by basal-like 20.26%.
To clarify the young epidemiological profile and the etiology of breast cancer a regional cancer registry is required. Furthermore, awareness campaigns are crucial to avoid having patients with aggressive forms of the disease. Therefore, to improve survival and reduce the morbidity of breast cancer patients.



Bray F, Ferlay J, Soerjomataram I, Siegel RL , Torre LA , Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov; 68(6):349-424. https://doi.org/10.3322/caac.21492

Washbrook E. Risk factors and epidemiology of breast cancer. Women’s Heal Med. Jan-Feb 2006; 3(1): 8-14. https://doi.org/10.1383/wohm.2006.3.1.8

Molinié F, Billon-Delacour S, Allioux C, Blais S, Bercelli P, Lombrail P.[Incidence and prognostic factors of breast cancer diagnosed within and outside of the organised screening program in the department of Loire-Atlantique (1991–2002)]. Rev Epidemiol Sante Publique.2008 Feb; 56(1): 41-49. https://doi.org/10.1016/j.respe.2008.01.001

Dean AG, Arner TG, Sunki GG, Friedman R, Lantinga M, Sangam S,et al. CDC - Epi InfoTM - Training Resources. Epi InfoTM, a database Stat. Progr public Heal. Prof. CDC, Atlanta, GA: USA; 2011.

Carey LA, Perou CM, Livasy CA, Dressler LG, Gowman D, Conway K, et al. [Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study]. JAMA. 2006 Jun 7; 295(21):2492-502. https://doi.org/10.1001/jama.295.21.2492

Parise CA, Bauer KR, Brown MM, Caggiano V. Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004. Breast J. Nov-Dec 2009; 15(6):593–602. https://doi.org/10.1111/j.1524-4741.2009.00822.x

Cohn BA, La Merrill M, Krigbaum NY, Yeh G, Park JS, Zimmerman L, et al. DDT Exposure in Utero and Breast Cancer. J Clin Endocrinol Metab. 2015 Aug; 100(8):2865-72. https://doi.org/10.1210/jc.2015-1841

Fenga C. Occupational exposure and risk of breast cancer. Biomed Rep. 2016 Mar; 4(3) 282-292. https://doi.org/10.3892/br.2016.575

Abbass F, Bennis S, Znati K, Akasbi Y, Amrani JK. Epidemiological and biologic profile of breast cancer in Fez-Boulemane, Morocco/Le profil epidemiologique et biologique du cancer du sein a Fes-Boulemane (Maroc). World Health Organization, 2011; 17(12).

[Accessed 30 Jun 2021]. Available From: https://go.gale.com/ps/i.do?id=GALE%7CA277519315&sid=googleScholar&v=2.1&it=r&linkaccess=abs&issn=10203397&p=HRCA&sw=w&userGroupName=anon%7E490b2442

Bounedjar A. Epidemiology and Characteristic of Breast Cancer in CHU Blida, Algeria. Pan Arab J Oncol. 2016; 9(2). [Accessed 30 Jun 2021]. Available From: https://www.amaac.org/images/files/PAJO/2016June3/2016.

Blamey RW, Stentam BH, Ball G, Blichert-toft M, Gataliotti L, Fourquet A, et al. ONCOPOOL – A European database for 16,944 cases of breast cancer. Eur J Cancer. 2010 Jan; 46(1): 56–71. https://doi.org/10.1016/j.ejca.2009.09.009

Fakhro AE, Fateha BE, al-Asheeri N, al-Ekri SA. Breast cancer: patient characteristics and survival analysis at Salmaniya medical complex, Bahrain. East Mediterr Health J. 1999 May; 5(3):340-9. [Accessed 30 Jun 2021]. Available From: https://apps.who.int/iris/handle/10665/118724

Zidan J, Sikorsky N, Basher W, Sharabi A, Friedman E, Steiner M. Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel. Int J Cancer. 2012 Aug 15; 131(4):924-9. https://doi.org/10.1002/ijc.26431

Telli ML, Chang ET, Kurian AW, Keegan TH, McClure LA, Lichtensztajn D, et al.“Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry,” Breast Cancer Res Treat. 2011 Jun;127(2):471-8.https://doi.org/10.1007/s10549-010-1173-8

Jack RH, Davies EA, Renshaw C, Tut Andrew, Grocock MJ, Coupland VH, et al. Differences in breast cancer hormone receptor status in ethnic groups: a London population. Eur J Cancer. 2013 Feb; 49 (3); 696 702.https://doi.org/10.1016/j.ejca.2012.09.012

Chouchane L, Boussen H, Sastry KSR. Breast cancer in Arab populations: molecular characteristics and disease management implications. Lancet Oncol. 2012 Sep;14(10):e417-24. https://doi.org/10.1016/s1470-2045(13)70165-7

Fourati A, Boussen H, El May MV, Goucha A, Dabbabi B, Gamoudi A, et al. Descriptive analysis of molecular subtypes in Tunisian breast cancer. Asia Pac J Clin Oncol. 2014 Jun; 10(2):e69-74. https://doi.org/10.1111/ajco.12034

Chahine G, Rassy EE, Khazzaka A, Saleh K, Rassy N, Khalife N, et al. Characteristics of incident female breast cancer in Lebanon, 1990–2013: Descriptive study of 612 cases from a hospital tumor registry. Cancer Epidemiol. 2015 Jun: 39(3):303-6. https://doi.org/10.1016/j.canep.2015.03.008

Fatemi HE, Chahbouni S, Jayi S, Moumma K, Melhouf MA, Bannani A, et al. Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco. Diagn Pathol. 2012 Dec 7; 7: 170. https://doi.org/10.1186/1746-1596-7-170

Al Tamimi DM, Shawarby MA, Ahmed A, Hassan AK, AlOdaini AA. Protein expression profile and prevalence pattern of the molecular classes of breast cancer - a Saudi population based study. BMC Cancer. 2010 Dec ; 10(1) : p. 223.https://doi.org/10.1186/1471-2407-10-223

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2018 Fatima Zahra Aznag et al.


Download data is not yet available.